Atlas Trials

Sirolimus for Focal Segmental Glomerulosclerosis

Clinical trial NCT00040508 · COMPLETED

Trial details

NCT number
NCT00040508
Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Focal Glomerulosclerosis
Start date
2002-06-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.